Results 251 to 260 of about 672,953 (296)

Inhibiting Serotonin Synthesis for the Treatment of Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Hansmann G, Bader M.
europepmc   +1 more source

Early Stent Frame Fracture of SAPIEN 3 Valve in the Pulmonary Position

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT A 15‐year‐old post‐REV patient underwent transcatheter pulmonary valve replacement with a 23 mm SAPIEN 3 for right ventricular outflow tract (RVOT) stenosis and severe regurgitation. At 9 months, recurrent stenosis revealed multiple frame fractures.
Raymond N. Haddad, Clément Batteux, Emre Belli, Sébastien Hascoët   +3 more
wiley   +1 more source

Emerging Pharmacological Approaches for the Treatment of Arterial Hypertension. [PDF]

Biomedicines
Schinzari F, Montenero R, Cardillo C, Tesauro M.   +3 more
europepmc   +1 more source

Comparison of Latest Generation Intra‐ and Supra‐Annular Self‐Expanding Transcatheter Heart Valves for Aortic Valve‐in‐Valve Procedures

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Valve‐in‐valve (ViV) procedures are an established therapy. Self‐expanding (SE) supra‐annular transcatheter heart valves (THV) achieve superior hemodynamics compared to balloon‐expandable (BE) intra‐annular THV, but influence of stent design versus valve position remains unclear.
Antonia Katharina Stötzel, Oliver D. Bhadra, Lara Waldschmidt, Till J. Demal, David Grundmann, Lisa Voigtländer, Stefan Blankenberg, Hermann Reichenspurner, Niklas Schofer, Andreas Schaefer   +9 more
wiley   +1 more source

Transcaval Transcatheter Aortic Valve Replacement: Clinical Outcomes From a TAVI Program Without Prior Transcaval Experience

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Despite the emergence of the transcaval (TCv) access route for transcatheter aortic valve implantation (TAVI) in the treatment of patients with hostile iliofemoral anatomy, the number of patients reported in clinical series of TCv TAVI has been relatively small (< 500 published cases). We assessed procedural and clinical outcomes in
Conor J. Doyle, Brian McGrath, Ronan Margey, Andrew Sharp, Andrew J. Mitchell, Ellen Beirne, Ivan P. Casserly   +6 more
wiley   +1 more source

Breathing New Life into Pulmonary Arterial Hypertension Treatment: Targeting Serotonin Synthesis with an Inhalation Approach. [PDF]

Am J Respir Cell Mol Biol
Lee MH, Kumar R.
europepmc   +1 more source

Perventricular Device Closure of Native Congenital Muscular Ventricular Septal Defects in Small Infants   $\hspace{0.17em}$ ≤ 5 kg: Single‐Center Study of the Risk Factors for Failure of the Intervention and Non‐Optimal Outcome

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background and Aims Perventricular device closure of muscular VSD in small infants is a less invasive option than surgical closure under cardiopulmonary bypass and offers better outcomes than palliative pulmonary artery banding. However, the specific risk factors that could affect procedural success and optimal outcomes have not been ...
Emine Hekim Yilmaz, Ilker Kemal Yucel, Murat Surucu, Huseyin Karadag, Ibrahim Halil Demir, Murat Cicek, Numan Ali Aydemir, Ahmet Celebi   +7 more
wiley   +1 more source

Raised plasma concentrations of brain natriuretic peptide in pulmonary arterial hypertension

, 1995
Neeraj Prasad, Chim C. Lang, Howard M. McAlpine, Anna Maria Choy, Thomas M. MacDonald, Allan D. Struthers   +5 more
openalex   +1 more source

Plasma Multiplatform Metabolomics Towards Evaluation of Gender Differences in Pulmonary Arterial Hypertension-A Pilot Study. [PDF]

Biomedicines
Wawrzyniak R, Gaillard T, Biesemans M, Zięba B, Lewicka E, Markuszewski M, Dąbrowska-Kugacka A.   +6 more
europepmc   +1 more source